Composition
- Active ingredients
- ERYTHROMYCIN ETHYLSUCCINATE EQ 200MG BASE/5ML; SULFISOXAZOLE ACETYL EQ 600MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA050529.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Pediazole
- Active substance
- erythromycin ethylsuccinate
- Route
- Oral
- Dosage form
- Granule
- Applicant
- Ross Labs
- Status
- Discontinued
- FDA approval
- 29 Nov 1979
- Application
- NDA050529-001